Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CERVICAL CARCINOMAS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 49 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Palmisano, GL; Pistillo, MP; Capanni, P; Pera, C; Nicolo, G; Salvi, S; Perdelli, L; Pasciucco, G; Ferrara, GB
      Investigation of HLA class I downregulation in breast cancer by RT-PCR

      HUMAN IMMUNOLOGY
    2. Sette, A; Chesnut, R; Fikes, J
      HLA expression in cancer: implications for T cell-based immunotherapy

      IMMUNOGENETICS
    3. Johnsen, AK; France, J; Nagy, N; Askew, D; Abdul-Karim, FW; Gerson, SL; Sy, MS; Harding, CV
      Systemic deficits in transporter for antigen presentation (TAP)-1 or proteasome subunit LMP2 have little or no effect on tumor incidence

      INTERNATIONAL JOURNAL OF CANCER
    4. Sano, T; Hikino, T; Xue, Q; Saito, T; Kashiwabara, K; Oyama, T; Nakajima, T
      Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma

      PATHOLOGY INTERNATIONAL
    5. Grandis, JR; Falkner, DM; Melhem, MF; Gooding, WE; Drenning, SD; Morel, PA
      Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: Clinical and immunogenetic consequences

      CLINICAL CANCER RESEARCH
    6. Orjuela, M; Castaneda, VP; Ridaura, C; Lecona, E; Leal, C; Abramson, DH; Orlow, I; Gerald, W; Cordon-Cardo, C
      Presence of human papilloma virus in tumor tissue from children with retinoblastoma: An alternative mechanism for tumor development

      CLINICAL CANCER RESEARCH
    7. Vambutas, A; Bonagura, VR; Steinberg, BM
      Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: Correlation of TAP-1 with disease

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    8. Georgopoulos, NT; Proffitt, JL; Blair, GE
      Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins

      ONCOGENE
    9. John, LSS; Sauter, ER; Herlyn, M; Litwin, S; Adler-Storthz, K
      Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53

      CANCER GENE THERAPY
    10. Bartels, PH; Thompson, D; Montironi, R; Hamilton, PW; Mariuzzi, GM; da Silva, VD
      Digital knowledge and diagnostic information

      JOURNAL OF HISTOTECHNOLOGY
    11. Lacey, JV; Brinton, LA; Barnes, WA; Gravitt, PE; Greenberg, MD; Hadjimichael, OC; McGowan, L; Mortel, R; Schwartz, PE; Kurman, RJ; Hildesheim, A
      Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix

      GYNECOLOGIC ONCOLOGY
    12. Riemersma, SA; Jordanova, ES; Schop, RFJ; Philippo, K; Looijenga, LHJ; Schuuring, E; Kluin, PM
      Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites

      BLOOD
    13. Ui, M; Mizutani, T; Takada, M; Arai, T; Ito, T; Murakami, M; Koike, C; Watanabe, T; Yoshimatsu, K; Iba, H
      Endogenous AP-1 levels necessary for oncogenic activity are higher than those sufficient to support normal growth

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    14. Hicklin, DJ; Marincola, FM; Ferrone, S
      HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

      MOLECULAR MEDICINE TODAY
    15. Ried, T; Heselmeyer-Haddad, K; Blegen, H; Schrock, E; Auer, G
      Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: A phenotype genotype correlation

      GENES CHROMOSOMES & CANCER
    16. Kleter, B; van Doorn, LJ; Schrauwen, L; Molijn, A; Sastrowijoto, S; ter Schegget, J; Lindeman, J; ter Harmsel, B; Burger, M; Quint, W
      Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus

      JOURNAL OF CLINICAL MICROBIOLOGY
    17. Kahn, E; Lizard, G; Pelegrini, M; Frouin, F; Roignot, P; Chardonnet, Y; Di Paola, R
      Four-dimensional factor analysis of confocal image sequences (4D-FAMIS) todetect and characterize low copy numbers of human papillomavirus DNA by FISH in HeLa and SiHa cells

      JOURNAL OF MICROSCOPY-OXFORD
    18. Johnsen, AK; Templeton, DJ; Sy, MS; Harding, CV
      Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis

      JOURNAL OF IMMUNOLOGY
    19. Pintos, J; Franco, EL; Black, MJ; Bergeron, J; Arella, M
      Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract

      CANCER
    20. BARTELS PH; MONTIRONI R; HAMILTON PW; THOMPSON D; VAUGHT L; BARTELS HG
      NUCLEAR CHROMATIN TEXTURE IN PROSTATIC LESIONS II - PIN AND MALIGNANCY ASSOCIATED CHANGES

      Analytical and quantitative cytology and histology
    21. Nagy, N; Vanky, F; Klein, E
      Tumor surveillance: expression of the transporter associated with antigen processing (TAP-1) in ex-vivo human tumor samples and its elevation by in vitro treatment with IFN-gamma and TNF-alpha

      IMMUNOLOGY LETTERS
    22. GALLOWAY DA
      IS VACCINATION AGAINST HUMAN-PAPILLOMAVIRUS A POSSIBILITY

      Lancet
    23. JOHNSEN A; FRANCE J; SY MS; HARDING CV
      DOWN-REGULATION OF THE TRANSPORTER FOR ANTIGEN PRESENTATION, PROTEASOME SUBUNITS, AND CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX IN TUMOR-CELL LINES

      Cancer research
    24. KOHLBERGER PD; KIRNBAUER R; BANCHER D; GITSCH G; REINTHALLER A; LEODOLTER S; TSCHACHLER E; KAINZ C; BREITENECKER G
      ABSENCE OF P53 PROTEIN OVEREXPRESSION IN PRECANCEROUS LESIONS OF THE VULVA

      Cancer
    25. MURRAY PG; CONSTANDINOU CM; CROCKER J; YOUNG LS; AMBINDER RF
      ANALYSIS OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I, TAP EXPRESSION,AND LMP2 EPITOPE SEQUENCE IN EPSTEIN-BARR VIRUS-POSITIVE HODGKINS-DISEASE

      Blood
    26. Kleter, B; van Doorn, LJ; ter Schegget, J; Schrauwen, L; van Krimpen, K; Burger, M; ter Harmsel, B; Quint, W
      Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses

      AMERICAN JOURNAL OF PATHOLOGY
    27. OKA K; NAKANO T; ARAI T
      EXPRESSION OF CATHEPSIN-D AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN STAGE-III CERVICAL CARCINOMAS

      International journal of gynecological cancer
    28. POLISCHOUK AG; SCOTNIKOVA OI; SERGEEVA NS; ZHARINOV GM; LEWENSOHN R; ZHIVOTOVSKY B
      RESPONSE TO RADIOTHERAPY OF HUMAN UTERINE CERVIX CARCINOMA IS NOT CORRELATED WITH REARRANGEMENTS OF THE HA-RAS-1 AND OR C-MYC GENES/

      European journal of cancer
    29. GARRIDO F; RUIZCABELLO F; CABRERA T; PEREZVILLAR JJ; LOPEZBOTET M; DUGGANKEEN M; STERN PL
      IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS-I PHENOTYPESIN HUMAN TUMORS

      Immunology today
    30. PAYNE PW; SEBO TJ; DOUDKINE A; GARNER D; MACAULAY C; LAM S; LERICHE JC; PALCIC B
      SPUTUM SCREENING BY QUANTITATIVE MICROSCOPY - A REEXAMINATION OF A PORTION OF THE NATIONAL-CANCER-INSTITUTE COOPERATIVE EARLY LUNG-CANCER STUDY

      Mayo Clinic proceedings
    31. ENGEL AM; SVANE IM; MADSEN MW; PEDERSEN M; WERDELIN O
      MOLECULAR ABERRATIONS IN THE MHC CLASS I-RESTRICTED PATHWAY FOR ANTIGEN PRESENTATION IN METHYLCHOLANTHRENE SARCOMAS FROM NUDE-MICE - DISCREPANCIES BETWEEN MHC MESSENGER-RNA AND SURFACE PROTEIN

      Clinical and experimental immunology
    32. VORA AR; RODGERS S; PARKER AJ; START R; REES RC; MURRAY AK
      AN IMMUNOHISTOCHEMICAL STUDY OF ALTERED IMMUNOMODULATORY MOLECULE EXPRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      British Journal of Cancer
    33. CHIBA I; SHINDOH M; YASUDA M; YAMAZAKI Y; AMEMIYA A; SATO Y; FUJINAGA K; NOTANI K; FUKUDA H
      MUTATIONS IN THE P53 GENE AND HUMAN PAPILLOMAVIRUS INFECTION AS SIGNIFICANT PROGNOSTIC FACTORS IN SQUAMOUS-CELL CARCINOMAS OF THE ORAL CAVITY

      Oncogene
    34. HOOS A; DINCAN C; GISSMANN L; ALTMANN A; MOMBURG F; NINDL I; OSEN W; SCHONNING BH; JOCHMUS I
      HUMAN PAPILLOMAVIRUS TYPE-16 (HPV 16) E7 AND MAJOR HISTOCOMPATIBILITYCOMPLEX (MHC) CLASS-I AND CLASS-II EXPRESSION IN HUMAN KERATINOCYTES IN CULTURE

      Archives of virology
    35. SINGAL DP; YE M; QIU XH
      MOLECULAR-BASIS FOR LACK OF EXPRESSION OF HLA CLASS-I ANTIGENS IN HUMAN SMALL-CELL LUNG-CARCINOMA CELL-LINES

      International journal of cancer
    36. SNIJDERS PJF; SCHOLES AGM; HART CA; JONES AS; VAUGHAN ED; WOOLGAR JA; MEJER CJLM; WALBOOMERS JMM; FIELD JK
      PREVALENCE OF MUCOSOTROPIC HUMAN PAPILLOMAVIRUSES IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK

      International journal of cancer
    37. KOUVIDOU C; RONTOGIANNI D; TZARDI M; DATSERIS G; PANAYIOTIDES I; DARIVIANAKI K; KARIDI E; DELIDES G; KANAVAROS P
      BETA(2)-MICROGLOBULIN AND HLA-DR EXPRESSION IN RELATION TO THE PRESENCE OF EPSTEIN-BARR-VIRUS IN NASOPHARYNGEAL CARCINOMAS

      Pathobiology
    38. POULIN N; SUSNIK B; GUILLAUD M; DOUDKINE A; WORTH A; PALCIC B
      HISTOMETRIC TEXTURE ANALYSIS OF DNA IN THIN-SECTIONS FROM BREAST BIOPSIES - APPLICATION TO THE DETECTION OF MALIGNANCY-ASSOCIATED CHANGES IN CARCINOMA IN-SITU

      Analytical and quantitative cytology and histology
    39. SUSNIK B; WORTH A; LERICHE J; PALCIC B
      MALIGNANCY-ASSOCIATED CHANGES IN THE BREAST - CHANGES IN CHROMATIN DISTRIBUTION IN EPITHELIAL-CELLS IN NORMAL-APPEARING TISSUE ADJACENT TO CARCINOMA

      Analytical and quantitative cytology and histology
    40. GOPALKRISHNA V; SRIVASTAVA AN; HEDAU S; SHARMA JK; DAS BC
      DETECTION OF HUMAN PAPILLOMAVIRUS DNA-SEQUENCES IN CANCER OF THE URINARY-BLADDER BY IN-SITU HYBRIDIZATION AND POLYMERASE CHAIN-REACTION

      Genitourinary medicine
    41. NURNBERG W; ARTUC M; VORBRUEGGEN G; KALKBRENNER F; MOELLING K; CZARNETZKI BM; SCHADENDORF D
      NUCLEAR PROTOONCOGENE PRODUCTS TRANSACTIVATE THE HUMAN PAPILLOMAVIRUSTYPE-16 PROMOTER

      British Journal of Cancer
    42. RANKI A; LASSUS J; NIEMI KM
      RELATION OF P53 TUMOR-SUPPRESSOR PROTEIN EXPRESSION TO HUMAN PAPILLOMAVIRUS (HPV) DNA AND TO CELLULAR ATYPIA IN MALE GENITAL WARTS AND IN PREMALIGNANT LESIONS

      Acta dermato-venereologica
    43. BIBBO M; XIAO J; CHRISTEN R; FITZPATRICK B; GALERADAVIDSON H; BARTELS PH; MINIMO C
      USE OF COMPUTER GRAPHIC FILLERS FOR THE NUCLEAR GRADING OF HEMATOXYLIN AND EOSIN-STAINED SPECIMENS FROM PROSTATIC LESIONS

      Analytical and quantitative cytology and histology
    44. BRACHMAN DG
      MOLECULAR-BIOLOGY OF HEAD AND NECK CANCER

      Seminars in oncology
    45. TATE JE; MUTTER GL; PRASAD CJ; BERKOWITZ R; GOODMAN H; CRUM CP
      ANALYSIS OF HPV-POSITIVE AND HPV-NEGATIVE VULVAR CARCINOMAS FOR ALTERATIONS IN C-MYC, HA-RAS, KI-RAS, AND N-RAS GENES

      Gynecologic oncology
    46. SNIJDERS PJF; STEENBERGEN RDM; TOP B; SCOTT SD; MEIJER CJLM; WALBOOMERS JMM
      ANALYSIS OF P53 STATUS IN TONSILLAR CARCINOMAS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS

      Journal of General Virology
    47. WOJNO KJ; OLSON JL; SHERMAN ME
      CYTOPATHOLOGY OF PLEURAL EFFUSIONS AFTER RADIOTHERAPY

      Acta cytologica
    48. CHRISTEN R; XIAO J; MINIMO C; GIBBONS G; FITZPATRICK BT; GALERADAVIDSON H; BARTELS PH; BIBBO M
      CHROMATIN TEXTURE FEATURES IN HEMATOXYLIN AND EOSIN STAINED PROSTATE TISSUE

      Analytical and quantitative cytology and histology
    49. PALCIC B; SUSNIK B; GARNER D; OLIVOTTO I
      QUANTITATIVE-EVALUATION OF MALIGNANT POTENTIAL OF EARLY BREAST-CANCERUSING HIGH-RESOLUTION IMAGE CYTOMETRY

      Journal of cellular biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 11:09:49